Type 2 radio bursts, interplanetary shocks and energetic particle events

Using the ISEE-3 radio astronomy experiment data 37 interplanetary (IP) type II bursts have been identified in the period September 1978 to December 1981. These events and the associated phenomena are listed. The events are preceded by intense, soft X ray events with long decay times (LDEs) and type II and/or type IV bursts at meter wavelengths. The meter wavelength type II bursts are usually intense and exhibit herringbone structure. The extension of the herringbone structure into the kilometer wavelength range results in the occurrence of a shock accelerated (SA) event. The majority of the interplanetary type II bursts are associated with energetic particle events. These results support other studies which indicate that energetic solar particles detected at 1 A.U. are generated by shock acceleration. From a preliminary analysis of the available data there appears to be a high correlation with white light coronal transients

Two classes of solar energetic particle events associated with impulsive and long duration soft X-ray flares

Solar energetic particle events observed in space have different properties depending on the class of associated flare. Impulsive flares, which occur low in the corona in regions of high energy density, are associated with particle events which are deficient in protons. These events are rarely associated with coronal mass ejections and interplanetary shocks. The vast majority of large, high energy proton events are associated with long duration flares, many of which are also associated with fast coronal mass ejections and strong interplanetary shocks. Such flare events originate relatively high in the corona

Sequence variation in the haemagglutinin-neuraminidase gene of human parainfluenza virus type 3 isolates in the UK

The sequence variation in a 934 base-pair region of the gene encoding the haemagglutinin-neuraminidase of five human parainfluenza virus type 3 (HPIV3) isolates was determined together with that of a prototype UK strain. All of the clinical isolates were from the Manchester area of the UK and were obtained in 1990. 1991 and 1993. The gene segment was amplified by the polymerase chain reaction using HPIVB-specific oligonucleotide primers. The nucleotide homology of the strains was high, around 99% and specific differences in the UK sequences when compared with that of the US prototype strain were identified. In addition, a number of isolate-specific differences were seen. No correlation was detected between the observed nucleotide mutations and the year of isolation, which supports the hypothesis that HPIV3 shows cocirculation of a heterogeneous population of viruses rather than varying with time in a linear fashion. However, the data suggested that geographically-defined genetic lineages of HPIV3 may exist

Type 2 solar radio events observed in the interplanetary medium. Part 1: General characteristics

Twelve type 2 solar radio events were observed in the 2 MHz to 30 kHz frequency range by the radio astronomy experiment on the ISEE-3 satellite over the period from September 1978 to December 1979. These data provide the most comprehensive sample of type 2 radio bursts observed at kilometer wavelengths. Dynamic spectra of a number of events are presented. Where possible, the 12 events were associated with an initiating flare, ground based radio data, the passage of a shock at the spacecraft, and the sudden commencement of a geomagnetic storm. The general characteristics of kilometric type 2 bursts are discussed

Fast drift kilometric radio bursts and solar proton events

Initial results of a comparative study of major fast drift kilometric bursts and solar proton events from Sep. 1978 to Feb. 1983 are presented. It was found that only about half of all intense, long duration ( 40 min above 500 sfu) 1 MHz bursts can be associated with F 20 MeV proton events. However, for the subset of such fast drift bursts accompanied by metric Type 2 and/or 4 activity (approximately 40% of the total), the degree of association with 20 MeV events is 80%. For the reverse association, it was found that proton events with J( 20 MeV) 0.01 1 pr cm(-2)s(-1)sr(-1)MeV(-1) were typically (approximately 80% of the time) preceded by intense 1 MHz bursts that exceeded the 500 sfu level for times 20 min (median duration approximately 35 min)

Comment on "Geoeffectiveness of halo coronal mass ejections" by N. Gopalswamy, S. Yashiro, and S. Akiyama

Comment on paper: Gopalswamy, N., S. Yashiro, and S. Akiyama (2007), Geoeffectiveness of halo coronal mass ejections, J. Geophys. Res., 112, A06112, doi:10.1029/2006JA012149 Gopalswamy et al. [2007] studied the geoeffectiveness of halo coronal mass ejections (CMEs) on the basis of solar observations during 1996-2005 and found that the geoeffectiveness of 229 frontside halo CMEs was 71%. Recently for observations of 305 frontside halo CMEs during 1997-2003 the geoeffectiveness was found to be 40% [Kim et al., 2005]. Complex analysis of both solar and interplanetary measurements showed that the geoeffectiveness of frontside halo CMEs is likely to be about 50% [Yermolaev et al., 2005; Yermolaev and Yermolaev, 2006]. Gopalswamy et al. [2007] did not discuss possible causes of this difference and were limited only to the general words: "The reason for the conflicting results (geoeffectiveness of CMEs ranging from 35% to more than 80%) may be attributed to the different definition of halo CMEs and geoeffectiveness." So, here we shall present our point of view on high geoeffectivenees of CME obtained in paper by Gopalswamy et al. [2007]

Forbush decreases and turbulence levels at CME fronts

We seek to estimate the average level of MHD turbulence near coronal mass ejection (CME) fronts as they propagate from the Sun to the Earth. We examine the cosmic ray data from the GRAPES-3 tracking muon telescope at Ooty, together with the data from other sources for three well observed Forbush decrease events. Each of these events are associated with frontside halo Coronal Mass Ejections (CMEs) and near-Earth magnetic clouds. In each case, we estimate the magnitude of the Forbush decrease using a simple model for the diffusion of high energy protons through the largely closed field lines enclosing the CME as it expands and propagates from the Sun to the Earth. We use estimates of the cross-field diffusion coefficient $D_{\perp}$ derived from published results of extensive Monte Carlo simulations of cosmic rays propagating through turbulent magnetic fields. Our method helps constrain the ratio of energy density in the turbulent magnetic fields to that in the mean magnetic fields near the CME fronts. This ratio is found to be $\sim$ 2% for the 11 April 2001 Forbush decrease event, $\sim$ 6% for the 20 November 2003 Forbush decrease event and $\sim$ 249% for the much more energetic event of 29 October 2003.Comment: Accepted for publication in Astronomy and Astrophysics. (Abstract abridged) Typos correcte

PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation.

A new approach to the management of non-small-cell lung cancer (NSCLC) has recently emerged that works by manipulating the immune checkpoint controlled by programmed death receptor 1 (PD-1) and its ligand programmed death ligand 1 (PD-L1). Several drugs targeting PD-1 (pembrolizumab and nivolumab) or PD-L1 (atezolizumab, durvalumab, and avelumab) have been approved or are in the late stages of development. Inevitably, the introduction of these drugs will put pressure on healthcare systems, and there is a need to stratify patients to identify those who are most likely to benefit from such treatment. There is evidence that responsiveness to PD-1 inhibitors may be predicted by expression of PD-L1 on neoplastic cells. Hence, there is considerable interest in using PD-L1 immunohistochemical staining to guide the use of PD-1-targeted treatments in patients with NSCLC. This article reviews the current knowledge about PD-L1 testing, and identifies current research requirements. Key factors to consider include the source and timing of sample collection, pre-analytical steps (sample tracking, fixation, tissue processing, sectioning, and tissue prioritization), analytical decisions (choice of biomarker assay/kit and automated staining platform, with verification of standardized assays or validation of laboratory-devised techniques, internal and external quality assurance, and audit), and reporting and interpretation of the results. This review addresses the need for integration of PD-L1 immunohistochemistry with other tests as part of locally agreed pathways and protocols. There remain areas of uncertainty, and guidance should be updated regularly as new information becomes available